Wenxuan Hu
899 Ping Hai Road
Suzhou, 215000, China
Suzhou, 215000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
SIRT5-dependent desuccinylation licenses UBR5-mediated degradation of TAMM41 to regulate mitochondrial metabolism in lung adenocarcinoma.
Journal: Biology direct
Published: March 08, 2026
Gαi1 and Gαi3 mediate IL-11-induced signal transduction and are potential therapeutic targets for LUAD.
Journal: Cell death & disease
Published: May 23, 2025
Efficacy of combined silk suture ligation and stapler versus stapler alone for vascular control in uniportal video-assisted thoracoscopic surgery lobectomy.
Journal: Journal of thoracic disease
Published: May 05, 2025
Inhalable myofibroblast targeting nanoparticles for synergistic treatment of pulmonary fibrosis.
Journal: Science advances
Published: April 30, 2025
Acetylation-dependent USP7-TRIM25 axis drives oncogenic progression in non-small cell lung cancer.
Journal: Cell death & disease
Published: March 20, 2025
SLC25A39 overexpression exacerbates lung adenocarcinoma progression and is negatively regulated by AFG3L2.
Journal: NPJ precision oncology
Published: February 28, 2025
Identification of G protein subunit alpha i3 as a promising oncotarget of LUAD.
Journal: Cellular signalling
Published: October 29, 2024
DRP2 promotes EMT and serves as a potential therapeutic target for LUAD treatment.
Journal: Scientific reports
Published: October 28, 2024
Mitochondrial transcription elongation factor TEFM promotes malignant progression of gliomas.
Journal: Cancer cell international
Published: September 17, 2024
Foxd3/SLC5A6 axis regulates apoptosis in LUAD cells by controlling mitochondrial biotin uptake.
Journal: Cellular signalling
Published: August 05, 2024
Identification of TEFM as a potential therapeutic target for LUAD treatment.
Journal: Journal of translational medicine
Published: April 26, 2024
Last Updated: 09/26/2026